Clinical Trial Update: Fractional CO2 Laser Assisted Photodynamic Therapy [Phase 2, Phase 3]

View source ↗

Summary

Completion of Phase 2 and Phase 3 trials evaluating Fractional CO2 Laser Assisted Photodynamic Therapy for actinic keratosis and basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Basal Cell Carcinoma

Drugs mentioned

• Fractional CO2 Laser Assisted Photodynamic Therapy

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Actinic Keratosis, Basal Cell Carcinoma | Phase 2, Phase 3 | Status: COMPLETED